Furthermore, lower cerebrospinal fluid SAMP levels in mild cognitive impairment (MCI) patients were associated with a higher risk of progression to Alzheimer’s Disease [64]. This evidence concerns the gene XPNPEP1 and early-onset autosomal dominant Alzheimer disease.